Oruka Therapeutics (ORKA) Times Interest Earned (2010 - 2022)
Oruka Therapeutics (ORKA) posted quarterly Times Interest Earned of -$0.2 for Q2 2024, up 99.54% year-over-year from -$0.1 in Q3 2023, and up 59.16% quarter-over-quarter from -$0.5 in Q1 2024.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Times Interest Earned (2010 - 2022) Analysis & Trends
Oruka Therapeutics' Times Interest Earned history runs 15 years deep, the most recent figure standing at -$0.2 for Q2 2024.
- In Q2 2024, Times Interest Earned rose 99.54% year-over-year to -$0.2; the TTM figure through Jun 2024 stood at -$0.45 (up 99.74% YoY), while the FY2023 annual figure was -$0.13, up 32.58% from the prior year.
- Times Interest Earned for Q2 2024 stood at -$0.2, up from -$0.5 in the prior quarter.
- The five-year high for Times Interest Earned was -$0.2 in Q2 2024, with the low at -$995.0 in Q3 2020.
- The 5-year median for Times Interest Earned is -$52.4 (2020), against an average of -$129.92.
- The sharpest annual moves came in 2020 and 2024: Times Interest Earned tumbled 1096.87% in 2020, then soared 99.54% in 2024.
- Oruka Therapeutics' Times Interest Earned stood at -$68.35 in 2020, then decreased by 25.92% to -$86.06 in 2021, then soared by 54.38% to -$39.26 in 2022, then sank by 55.76% to -$61.15 in 2023, then surged by 99.67% to -$0.2 in 2024.
- Business Quant data shows ORKA's Times Interest Earned at -$0.2 in Q2 2024, -$0.5 in Q1 2024, and -$61.15 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Oruka Therapeutics | 5.85 Bn | 4.12 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -850.67 |
| Mar 31, 2022 | -1,638.50 |
| Sep 30, 2020 | -995.00 |
| Jun 30, 2020 | -436.67 |
| Mar 31, 2020 | -335.00 |
| Sep 30, 2019 | -1,247.00 |
| Jun 30, 2019 | -502.67 |
| Mar 31, 2019 | -593.67 |
| Sep 30, 2018 | -831.00 |
| Jun 30, 2018 | -718.67 |
| Mar 31, 2018 | -924.33 |
| Sep 30, 2017 | -2,237.50 |
| Jun 30, 2017 | -2,779.50 |
| Mar 31, 2017 | -2,190.50 |
| Sep 30, 2015 | -2,817.00 |
| Jun 30, 2015 | -1,359.50 |
| Mar 31, 2015 | -2,744.00 |
| Sep 30, 2014 | -2,285.00 |
| Jun 30, 2014 | -2,406.00 |
| Mar 31, 2014 | -2,390.00 |